Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Endometrial Neoplasms × Hysterectomy × Clear all

Status

Completed 3 Recruiting 2 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Endometrial Neoplasms 1 Carcinoma, Endometrioid 1

Interventions

Paclitaxel 12 pembrolizumab 11 Carboplatin 9 durvalumab 4 Observation 4 Letrozole 4 Everolimus 4 lenvatinib 3 dostarlimab 3 atezolizumab 3 Taxes 3 Surveys and Questionnaires 3 Specimen Handling 3 Doxorubicin 3 sacituzumab govitecan 2 rucaparib 2 olaparib 2 cabozantinib 2 abemaciclib 2 Magnetic Resonance Spectroscopy 2 Cisplatin 2 Brachytherapy 2 Blood Specimen Collection 2 Biopsy 2 Bevacizumab 2 talazoparib 1 spartalizumab 1 sodium-iodide symporter 1 selinexor 1 ruxolitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06800677 2025-01-30

BioMEC

University of Manchester

Active not recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡